EFFECTS OF TREATMENT WITH SIMVASTATIN AND PRAVASTATIN ON COGNITIVE FUNCTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA

被引：42

作者：

CUTLER, N

SRAMEK, J

VEROFF, A

BLOCK, G

STAUFFER, L

LINES, C

机构：

[1] CALIF CLIN TRIALS,BEVERLY HILLS,CA 90211

[2] MERCK SHARP & DOHME LTD,RES LABS,BLUE BELL,PA 19422

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1995年 / 39卷 / 03期

关键词：

SIMVASTATIN; PRAVASTATIN; CHOLESTEROL; COGNITIVE FUNCTION;

D O I：

10.1111/j.1365-2125.1995.tb04458.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The effects of equi-efficacious doses of the cholesterol-lowering drugs simvastatin (20 mg day(-1)) and pravastatin (40 mg day(-1)) on tests of cognitive function were investigated in a double-blind, placebo-controlled, 2-period (4 weeks per period), incomplete block, crossover study of 36 patients (24 per treatment) with hypercholesterolaemia. After 4 weeks neither of the active treatments differed significantly from placebo on any cognitive measure.

引用

收藏

页码：333 / 336

页数：4

相关论文

共 13 条

[1] CONCENTRATIONS OF PRAVASTATIN AND LOVASTATIN IN CEREBROSPINAL-FLUID IN HEALTHY-SUBJECTS [J].

BOTTI, RE ;

TRISCARI, J ;

PAN, HY ;

ZAYAT, J .

CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) :256-261

[2] MODELING DEMENTIA - EFFECTS OF SCOPOLAMINE ON MEMORY AND ATTENTION [J].

BROKS, P ;

PRESTON, GC ;

TRAUB, M ;

POPPLETON, P ;

WARD, C ;

STAHL, SM .

NEUROPSYCHOLOGIA, 1988, 26 (05) :685-700

[3]

ECKERNAS SA, 1993, BRIT J CLIN PHARMACO, V35, P284

[4] THE PHARMACODYNAMICS OF DIPHENHYDRAMINE-INDUCED DROWSINESS AND CHANGES IN MENTAL PERFORMANCE [J].

GENGO, F ;

GABOS, C ;

MILLER, JK .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) :15-21

[5]

GENGO F, 1994, IN PRESS CLIN CARDIO

[6] DO CHOLESTEROL-LOWERING AGENTS AFFECT BRAIN ACTIVITY - A COMPARISON OF SIMVASTATIN, PRAVASTATIN, AND PLACEBO IN HEALTHY-VOLUNTEERS [J].

HARRISON, RWS ;

ASHTON, CH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (03) :231-236

[7] DEFINED DAILY DOSES IN RELATION TO HYPOLIPEMIC EFFICACY OF LOVASTATIN, PRAVASTATIN, AND SIMVASTATIN [J].

ILLINGWORTH, DR ;

ERKELENS, DW ;

KELLER, U ;

THOMPSON, GR ;

TIKKANEN, MJ .

LANCET, 1994, 343 (8912) :1554-1555

[8] 3-YEAR FOLLOW-UP OF THE OXFORD-CHOLESTEROL-STUDY - ASSESSMENT OF THE EFFICACY AND SAFETY OF SIMVASTATIN IN PREPARATION FOR A LARGE MORTALITY STUDY [J].

KEECH, A ;

COLLINS, R ;

MACMAHON, S ;

ARMITAGE, J ;

LAWSON, A ;

WALLENDSZUS, K ;

FATEMIAN, M ;

KEARNEY, E ;

LYON, V ;

MINDELL, J ;

MOUNT, J ;

PAINTER, R ;

PARISH, S ;

SLAVIN, B ;

SLEIGHT, P ;

YOUNGMAN, L ;

PETO, R .

EUROPEAN HEART JOURNAL, 1994, 15 (02) :255-269

[9] INVESTIGATION OF THE SEDATIVE AND COGNITIVE EFFECTS OF CYCLOBENZAPRINE COMPARED WITH DIPHENHYDRAMINE AND PLACEBO USING A COMPUTERIZED TEST BATTERY [J].

LINES, C ;

DAWSON, C ;

AMBROSE, J ;

PANEBIANCO, D ;

CHENG, K ;

TRAUB, M .

DRUG DEVELOPMENT RESEARCH, 1992, 27 (01) :33-44

[10]

PRESTON GC, 1988, PSYCHOPHARMACOLOGY, V95, P208